The Audited Financial Results and Statements of the Company (Standalone and Consolidated) for the Quarter and Year ended March 31, 2025, based on the recommendation of the Audit Committee.

pdf

Aarti Pharmalabs Ltd.

10 May 2025

879.20

1.03%

Annual Report

Annual report for Aarti Pharmalabs Ltd. for FY-2025

None

pdf

Aarti Pharmalabs Ltd.

05 May 2025

879.20

1.03%

Company Update

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

This is to inform you that the Earnings Conference Call for Investors and Analysts,which would be a Group meet, has been scheduled on Monday, May 12, 2025 at 4:00 P.M. (IST) to discuss the Company''s Q4-FY25/FY25 Results.

pdf

Aarti Pharmalabs Ltd.

29 Apr 2025

879.20

1.03%

Company Update

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release intimation under Regulation 30 of SEBI LODR, 2015

pdf

Aarti Pharmalabs Ltd.

25 Apr 2025

879.20

1.03%

Board Meeting

Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Audited Financial Results For The Year …

BSE India

Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 ,inter alia, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2025 and recommendation of dividend, if any, for the financial year ended March 31, 2025.

pdf